SLC16A2 and hyperinsulinemic hypoglycemia, familial, 4: Altogether, the findings of the present work indicate that the administration of THs by intranasal delivery is not suitable for the treatment of MCT8 deficiency, as this delivery route does not facilitate direct nose-to-brain transport of THs that would potentially ameliorate the brain hypothyroidism.